Bariatric Medicine Obesity Medicine Non-surgical Weight Loss Options & Orbera® Gastric Balloon
Our specialty-trained, weight loss certified providers are dedicated to improving health and wellness for patients affected by the disease of obesity who are interested in a non-surgical approach. We believe each patient requires counseling, education and support with nutrition, physical activity, behavior modification combined with meal replacements and the possibility of weight loss medications to meet their goals of sustained weight loss.
Our medical weight loss program is an option for Back-On-Track Surgical Weight Loss patients as well.
Who benefits from a Bariatric Medical Weight Loss Program?
Those with a BMI of 30 or more can benefit from a medical weight loss program that includes prescription medication and supervised diet and exercise programs. Medical Weight Loss is also helpful for those with other health conditions like diabetes, hypertension, fatty liver (steatosis/steatohepatitis), obstructive sleep apnea, controlled cardiovascular disease, osteoarthritis, gout, infertility, polycystic ovarian syndrome, and insulin resistance.
Who benefits from a Bariatric Non-Surgical Weight Loss Program?
Those with a BMI of 30 or more who are looking to learn portion control can benefit from the Orbera® Gastric Balloon. The technology and design of the Orbera balloon helps patients lose up to 3.1x the weight of diet and exercise alone. It is placed temporarily in your stomach for six months and can help patients lose 48% more* than other FDA-approved gastric balloons.
Who benefits from a Minimally Invasive Bariatric Program?
For those with a BMI of 30 or more who are looking for a long-term, sustainable, and customizable solution, the LAP-BAND® is an adjustable gastric banding system that has been designed and engineered to help with safe and effective weight loss. Endorsed by Keith McEwen M.D. and other leading surgeons, the procedure has been performed over 1,000,000 times since 1993 worldwide**, it’s covered by most insurance companies and backed by over 25 years of clinical evidence.
*Orbera® US FDA Pivotal Study & Obalon US FDA Pivotal Study.
**Data on file. ReShape Lifesciences Inc.